Cargando…
Expression and Characterization of Yeast Derived Chikungunya Virus Like Particles (CHIK-VLPs) and Its Evaluation as a Potential Vaccine Candidate
Chikungunya virus (CHIKV) has emerged as a global health concern due to its recent spread in both old and new world. So far, no CHIKV specific drug or vaccine is licensed for human use. In this study, we report production of Chikungunya virus like particles (CHIK-VLPs) using novel yeast expression s...
Autores principales: | Saraswat, Shweta, Athmaram, T. N., Parida, Manmohan, Agarwal, Ankita, Saha, Amrita, Dash, Paban Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939942/ https://www.ncbi.nlm.nih.gov/pubmed/27399001 http://dx.doi.org/10.1371/journal.pntd.0004782 |
Ejemplares similares
-
The “Chik Sign” in Neonatal Chikungunya
por: Chandramathi, Jayasree, et al.
Publicado: (2020) -
Vector-delivered artificial miRNA effectively inhibited replication of Chikungunya virus
por: Saha, Amrita, et al.
Publicado: (2016) -
Chikungunya in an Infant: Diffuse Hyperpigmentation and the “Chik Sign”
por: Ramani, Jami Rupa, et al.
Publicado: (2021) -
Identification of 2,4-Diaminoquinazoline Derivative as a Potential Small-Molecule Inhibitor against Chikungunya and Ross River Viruses
por: Saha, Amrita, et al.
Publicado: (2023) -
Molecular and Virological Investigation of a Focal Chikungunya Outbreak in Northern India
por: Soni, Manisha, et al.
Publicado: (2013)